These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 207494)

  • 21. Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog.
    Hashimoto N; Ishikawa Y; Utsunomiya J
    J Surg Res; 1989 Jan; 46(1):35-40. PubMed ID: 2644488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of insulin and glucagon in the liver (via portal vein catheter or with liposomes) does not stimulate liver cell regeneration after partial hepatectomy in normal or portocaval shunted rats.
    Freise J; Mueller WH; Broelsch CE
    Res Exp Med (Berl); 1982; 180(1):31-9. PubMed ID: 7043683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic insufficiency after portacaval shunting is prevented by prior intraportal pancreatic islet autotransplantation.
    Callery MP; Ricordi C; Scharp DW; Kamei T; Swanson CJ; Lacy PE; Flye MW
    Surgery; 1989 Aug; 106(2):257-65; discussion 265-6. PubMed ID: 2503900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormonal factors concerned with liver regeneration.
    Bucher NL; Patel U; Cohen S
    Ciba Found Symp; 1977; (55):95-107. PubMed ID: 306914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of beta-endorphin on biogenic amines, insulin, and glucagon levels in the hepatic portal circulation of normal and pancreatectomized dogs.
    Hussain MN; Kikuchi K; Cukerman E; Sirek A; Sirek OV
    Endocrinology; 1986 Aug; 119(2):685-90. PubMed ID: 2942391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study of protective effects of hepatotrophic factors on hepatic functions in rats with portal hypertension after portacaval shunt].
    Jiang P; Zhao JM; Zhang ZT
    Zhonghua Yi Xue Za Zhi; 2010 Dec; 90(48):3440-3. PubMed ID: 21223822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraportal insulin protects from the liver injury of portacaval shunt in dogs.
    Starzl TE; Porter KA; Putnam CW
    Lancet; 1975 Dec; 2(7947):1241-2. PubMed ID: 53727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of arterial or portal ischemia on survival and metabolism of partially and totally depancreatized dogs.
    Rappaport AM; Kawamura T; Knoblauch M; Cowan JS; Ohira S; Kalnins A; Empey G
    Z Exp Chir; 1975; 8(6):326-42. PubMed ID: 1053192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An experimental study of the role of portal vein blood factors in the regeneration of the liver after partial hepatectomy].
    Suenaga M
    Nihon Geka Gakkai Zasshi; 1983 May; 84(5):424-36. PubMed ID: 6674804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sympathetic drive to liver and nonhepatic splanchnic tissue during prolonged exercise is increased in diabetes.
    Coker RH; Krishna MG; Zinker BA; Allen EJ; Lacy DB; Wasserman DH
    Metabolism; 1997 Nov; 46(11):1327-32. PubMed ID: 9361694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of portal hepatotrophic factors in hepatology.
    Popper H
    Gastroenterology; 1974 Jun; 66(6):1227-33. PubMed ID: 4364185
    [No Abstract]   [Full Text] [Related]  

  • 34. Hyperinsulinemia and hyperglucagonemia in fasted rats during liver regeneration.
    Cornell RP
    Am J Physiol; 1981 Feb; 240(2):E112-8. PubMed ID: 7008625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatotrophic factors in liver growth and atrophy.
    Rozga J; Jeppsson B; Bengmark S
    Br J Exp Pathol; 1985 Dec; 66(6):669-78. PubMed ID: 4084448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splanchnic glucagon kinetics in exercising alloxan-diabetic dogs.
    Coker RH; Lacy DB; Krishna MG; Wasserman DH
    J Appl Physiol (1985); 1999 May; 86(5):1626-31. PubMed ID: 10233127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatotrophic effects of pancreatic and gastrointestinal hormones in the rat in vivo and in vitro.
    Junge U; Creutzfeldt W
    Ciba Found Symp; 1977; (55):269-83. PubMed ID: 248003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnitude of negative arterial-portal glucose gradient alters net hepatic glucose balance in conscious dogs.
    Pagliassotti MJ; Myers SR; Moore MC; Neal DW; Cherrington AD
    Diabetes; 1991 Dec; 40(12):1659-68. PubMed ID: 1684554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver atrophy, hypertrophy and regenerative hyperplasia in the rat: the relevance of blood flow.
    Blumgart LH
    Ciba Found Symp; 1977; (55):181-205. PubMed ID: 248000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut and liver fat metabolism in depancreatized dogs: effects of exercise and acute insulin infusion.
    Namdaran K; Bracy DP; Lacy DB; Johnson JL; Bupp JL; Wasserman DH
    J Appl Physiol (1985); 1997 Oct; 83(4):1339-47. PubMed ID: 9338445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.